Teladoc Health Statistics
Total Valuation
Teladoc Health has a market cap or net worth of MXN 23.30 billion. The enterprise value is 30.84 billion.
Market Cap | 23.30B |
Enterprise Value | 30.84B |
Important Dates
The next estimated earnings date is Friday, July 25, 2025.
Earnings Date | Jul 25, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
Current Share Class | 175.43M |
Shares Outstanding | n/a |
Shares Change (YoY) | +3.85% |
Shares Change (QoQ) | +0.80% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 164.84M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 0.45 |
PB Ratio | 0.80 |
P/TBV Ratio | n/a |
P/FCF Ratio | 3.95 |
P/OCF Ratio | 3.79 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 35.34, with an EV/FCF ratio of 5.23.
EV / Earnings | -1.49 |
EV / Sales | 0.63 |
EV / EBITDA | 35.34 |
EV / EBIT | n/a |
EV / FCF | 5.23 |
Financial Position
The company has a current ratio of 1.68, with a Debt / Equity ratio of 1.11.
Current Ratio | 1.68 |
Quick Ratio | 1.51 |
Debt / Equity | 1.11 |
Debt / EBITDA | 34.85 |
Debt / FCF | 5.50 |
Interest Coverage | -7.80 |
Financial Efficiency
Return on equity (ROE) is -54.49% and return on invested capital (ROIC) is -3.38%.
Return on Equity (ROE) | -54.49% |
Return on Assets (ROA) | -3.00% |
Return on Invested Capital (ROIC) | -3.38% |
Return on Capital Employed (ROCE) | -7.49% |
Revenue Per Employee | 10.31M |
Profits Per Employee | -4.09M |
Employee Count | 5,500 |
Asset Turnover | 0.66 |
Inventory Turnover | 21.44 |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -28.35% in the last 52 weeks.
Beta (5Y) | n/a |
52-Week Price Change | -28.35% |
50-Day Moving Average | 143.97 |
200-Day Moving Average | 180.20 |
Relative Strength Index (RSI) | 42.30 |
Average Volume (20 Days) | 880 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | 3.90 |
Income Statement
In the last 12 months, Teladoc Health had revenue of MXN 52.18 billion and -20.69 billion in losses. Loss per share was -120.18.
Revenue | 52.18B |
Gross Profit | 36.77B |
Operating Income | -3.81B |
Pretax Income | -20.96B |
Net Income | -20.69B |
EBITDA | 670.83M |
EBIT | -3.81B |
Loss Per Share | -120.18 |
Balance Sheet
The company has 24.39 billion in cash and 32.43 billion in debt, giving a net cash position of -8.04 billion.
Cash & Cash Equivalents | 24.39B |
Total Debt | 32.43B |
Net Cash | -8.04B |
Net Cash Per Share | n/a |
Equity (Book Value) | 29.17B |
Book Value Per Share | 166.34 |
Working Capital | 13.27B |
Cash Flow
In the last 12 months, operating cash flow was 6.15 billion and capital expenditures -252.77 million, giving a free cash flow of 5.89 billion.
Operating Cash Flow | 6.15B |
Capital Expenditures | -252.77M |
Free Cash Flow | 5.89B |
FCF Per Share | n/a |
Margins
Gross margin is 70.48%, with operating and profit margins of -7.31% and -39.66%.
Gross Margin | 70.48% |
Operating Margin | -7.31% |
Pretax Margin | -40.18% |
Profit Margin | -39.66% |
EBITDA Margin | 1.29% |
EBIT Margin | -7.31% |
FCF Margin | 11.29% |
Dividends & Yields
Teladoc Health does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.85% |
Shareholder Yield | n/a |
Earnings Yield | -88.80% |
FCF Yield | 25.29% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | n/a |
Lynch Upside | n/a |
Graham Number | n/a |
Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
Teladoc Health has an Altman Z-Score of -5.33. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -5.33 |
Piotroski F-Score | n/a |